PARI Issued US Patent for eFlow; Device Innovations Lead to Greater Efficiency in Drug Delivery
PARI has been granted US Patent 6,962,151 relating to technological advances in the eFlow electronic nebulizer that result in significant improvements in aerosol medication delivery. This technology aerosolizes medication more efficiently, so patients experience dramatically shorter treatment times while receiving complete therapies…[more]